Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by steadfaston Nov 14, 2021 8:41am
445 Views
Post# 34124406

SVA should be trading at $3.40 minimum

SVA should be trading at $3.40 minimumSemma was purchased for $950M U.S.
SVA should be worth minimum $1B U.S. = $1.25B Can
Total shares    fully diluted 365,714,353 round to 366M div by $1.25B  = $3.40 Can
SVA are paying Life Sciences $262,500 Can per yr + expenses for I.R.
    "   "      "       Ray Matthews$108,000 Can per yr
Total                                      $370,500
Time for these IR guys to perform and get the stock to $3.40 min
Haven't seen a lot of volume on Chicago exchange past few weeks vs Can Exchanges
SVA has broken out on the Charts, it is PERFORMANCE TIME NOW FOR IR GUYS/GALS
Time for Board of Director's to start Cracking the Whip
Where is Cannacord Analyst Report - promised almost a year ago?
Time for Sense of Urgency & Do It Now Attitude - TIME TO SUCCEED
NOW IS THE TIME TO SIGN A DEAL


<< Previous
Bullboard Posts
Next >>